Refractory Hematologic Malignancy

specific

A hematologic malignancy that is resistant to treatment.

19

Centers

18

Active Trials

Cancer Funding

Top Centers for Refractory Hematologic Malignancy(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.8
2
NCI Comprehensive
Active Research Program
53.8
3
NCI Comprehensive
Active Research Program
53.8
4
NCI Comprehensive
Active Research Program
53.8
5
NCI Comprehensive
Active Research Program
53.8
6
NCI Comprehensive
Active Research Program
53.8
7
NCI Comprehensive
Active Research Program
53.8
8
NCI Comprehensive
Active Research Program
53.8
9
NCI Comprehensive
Active Research Program
53.8
10
NCI Comprehensive
Active Research Program
53.8
11
NCI Comprehensive
Active Research Program
53.8
12
Active Research Program
53.8
13
NCI Clinical
Active Research Program
53.8
14
Active Research Program
53.8
15
Active Research Program
53.8
16
Active Research Program
53.8
17
Active Research Program
53.8
18
Active Research Program
53.8
19
NCI Comprehensive
31.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →